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Introduction: Bronchoscopic intervention in patients with malig-
nant central airway obstruction provides initial palliation and stabi-
lization of the airway, allowing the possibility of other effective
therapeutic modalities, such as surgery, radiation, or chemotherapy.
In critically ill patients, however, the only studies of bronchoscopic
intervention are relatively small series.
Methods: To describe the advantages and limitations of rigid
bronchoscopic intervention in critically ill patients, we reviewed the
medical records of 36 patients (26 men; median age, 62 years; range,
29 to 76 years) who underwent emergency airway intervention for
malignant central airway obstruction.
Results: Dyspnea was relieved in 34 of 36 patients (94.4%). After
the airway was widened, additional definitive therapeutic modalities
were used for 21 of 34 patients (61.8%). Patients who underwent
additional definitive therapy after bronchoscopic intervention sur-
vived longer (median, 38.2 months; range 1.7 to 57.0 months) than
those who did not (median, 6.2 months; range, 0.1 to 33.7 months;
p  0.001).
Conclusions: These data show that rigid bronchoscopic intervention
in critically ill patients with malignant central airway obstruction
may be temporarily life-saving and, in some patients, may serve as
a “bridge” to allow time for additional therapies for longer survival.
Key Words: Respiratory insufficiency, Airway obstruction, Neo-
plasms.
(J Thorac Oncol. 2006;1: 319–323)
Malignant central airway obstruction may have minimalsymptoms until the airway becomes critically nar-
rowed, but then results in life-threatening dyspnea because of
impending respiratory failure.1–4 Although surgical resection
and reconstruction provide the best opportunity for definitive
management, most patients with malignant central airway
obstruction cannot undergo resection because of anatomical
limitations, metastatic disease, or poor medical condition.3 In
addition, prompt endotracheal intubation might be impossible
and sometimes dangerous, leading to a fatal outcome. For
these patients, rigid bronchoscopic intervention provides the
most appropriate method of maintaining airway patency, as
well as the best opportunity for definitive therapeutic modal-
ities, such as surgery,3–8 radiation,3 and chemotherapy.9
To describe the role of rigid bronchoscopic intervention
in critically ill patients, we retrospectively reviewed the
medical records of patients who had malignant central airway
obstruction and underwent emergency bronchoscopic inter-
vention.
PATIENTS AND METHODS
Thirty-six patients who underwent emergency rigid
bronchoscopy for malignant central airway obstruction at
Samsung Medical Center, Seoul, Korea, between January
1999 and December 2003 were included. All the patients
were referred to the emergency room because of severe
dyspnea. They needed intubation or at least oxygen by mask
to maintain oxygenation. Patients who could breathe unaided
could only do so in the sitting position and could not eat or
sleep. Stridor was audible at rest. On bronchoscopy, there
was almost complete central airway obstruction. There were
26 men and 10 women in the study. The age of the patients
ranged from 29 to 76 years, with a median age of 62 years.
The etiologies of the central airway obstruction are summa-
rized in Table 1. Ten patients (27.8%) had a primary airway
tumor (adenoid cystic carcinoma in eight, mucoepidermoid
carcinoma in one, primary tracheal squamous cell carcinoma
in one). Twenty-two patients (61.1%) had central airway
obstruction from local extension (lung cancer in 11, esopha-
geal cancer in 7, thyroid cancer in 4). In four patients
(11.1%), metastatic carcinoma (one renal cell carcinoma, one
hepatocellular carcinoma, one cervix cancer, one bladder
cancer) obstructed the airway. Of the 36 patients, 20 (55.6%)
had previously undergone therapeutic modalities: surgical
resection in nine patients, combined chemoradiation in seven,
chemotherapy in two, and radiation alone in two. Previous
surgery had been performed for lung (n  4), tracheal (n 
2), thyroid (n  1), or esophageal (n  3) cancer. The
remaining 16 patients had undergone no previous therapy.
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All patients underwent rigid bronchoscopy within 24
hours after arriving at the emergency room. Rigid bronchos-
copy was performed under general anesthesia using intrave-
nous propofol injection. After the induction of anesthesia, the
patients were intubated with a rigid bronchoscope tube (Hop-
kins, Karl-Storz, Tuttlingen, Germany). A flexible broncho-
scope (EVIS BF 1T240; Olympus, Tokyo, Japan) was intro-
duced through the rigid bronchoscope tube, and the narrowed
central airway was evaluated. When indicated, biopsy spec-
imens were obtained for pathologic examination. In every
case, the obstructed airway was dilated gently using an 8-mm
rigid bronchoscope tube initially and then progressively
larger bronchoscope tubes until an adequate airway caliber
was established. When indicated, a controlled radial expan-
sion balloon (Boston Scientific, Boston, MA) was used to
enlarge the airway sufficiently to allow bronchoscopic dila-
tion (n  6). Any intraluminal mass was removed mechani-
cally using rigid bronchoscopic forceps or a snare. Fre-
quently, a neodymium-yttrium aluminum garnet (Nd-YAG)
laser (20 Watts; LaserSonics, Milpitas, CA) was used to
ablate the residual endobronchial tumor or to cauterize the
tumor bed after most of the tumor had been excised (n 28).
After mechanical dilation, the airway was maintained by
inserting a silicone stent (Dumon-style stent, Bryan Corp.,
Woburn, MA; Natural stent, TNO Corp., Seoul, Korea) in
patients whose airway was not maintained because of extrin-
sic compression or malacia (n  19).10–12 The silicone stents
were inserted through the rigid bronchoscope using a previ-
ously described technique.11
We reviewed the medical records and procedure notes
to determine the patients’ demographic characteristics, un-
derlying malignancy, previous therapeutic modalities, type of
airway obstruction, techniques applied during rigid bronchos-
copy, and occurrence of procedure-related complications. In
addition, any additional definitive therapy after broncho-
scopic intervention (surgery, radiation, or chemotherapy) and
survival were investigated. Survival was assessed through
April 30, 2005 (median, 46 months; range, 14 to 69 months).
Death was confirmed from the medical records or by calling
the patient’s family.
Data are presented as the median (range) for continuous
variables and as percentages for discrete variables. For the
survival analysis, time zero was defined as the date of rigid
bronchoscopy. The cumulative survival was estimated using
the Kaplan-Meier method, and the difference in survival was
analyzed using the log-rank test.
RESULTS
General Characteristics
In all 36 patients, bronchoscopic intervention was per-
formed within 24 h after arrival at the emergency room. The
bronchoscopic findings and treatment modalities are summa-
rized in Table 2. The trachea was involved in 27 patients
(75.0%), carina in two (5.6%), and main bronchi in seven
(19.5%; 5 left main, 2 right main). Two patients (5.6%) had
purely extrinsic compression of the airway requiring dilata-
tion and stenting; in 16 patients (44.4%), an intraluminal
mass produced the airway obstruction. In 18 patients
(50.0%), both extrinsic airway compression and an intralu-
minal mass caused the airway obstruction, requiring mechan-
ical debridement and stenting.
Overall Outcomes
Of the 36 patients, 34 (94.4%) had a successful out-
come after emergency bronchoscopic intervention. A suc-
cessful outcome was accompanied by subjective improve-
ment in the symptoms and radiographic findings (Fig. 1).
Only one patient required an immediate repeat bronchoscopy
after the initial intervention, as a result of persistent airway
obstruction. After removing additional tumor, the airway was
restored successfully, and the patient was treated with pallia-
tive radiation. Another patient required 3 days of mechanical
ventilation for unresolved respiratory failure but was weaned
successfully and underwent elective surgery.
After an immediate successful outcome, further bron-
choscopic interventions were required to maintain airway
patency in seven of the 27 patients with inoperable tumors
(31.8%) after follow-up periods ranging from 1.9 to 26.5
months (median, 8.8 months).
TABLE 1. Etiology of malignant central airway obstruction
Diagnosis n (%)
Primary airway tumor 10 (27.8)
Adenoid cystic carcinoma 8
Mucoepidermoid carcinoma 1
Squamous cell carcinoma 1
Local extension 22 (61.1)
Lung cancer 11
Esophageal cancer 7
Thyroid cancer 4
Metastatic disease 4 (11.1)
Renal cell carcinoma 1
Hepatocellular carcinoma 1
Cervix cancer 1
Bladder cancer 1
TABLE 2. Bronchoscopic findings and type of
bronchoscopic intervention
n (%)
Location of lesion
Trachea 27 (75.0)
Carina 2 (5.6)
Main bronchi 7 (19.5)
Type of lesion
Intraluminal mass 16 (44.4)
Extrinsic compression 2 (5.6)
Mixed lesion 18 (50.0)
Type of bronchoscopic intervention
Mechanical debridement 22
Stenting 19
Laser cauterization 14
Ballooning 4
Jeon et al. Journal of Thoracic Oncology • Volume 1, Number 4, May 2006
Copyright © 2006 by the International Association for the Study of Lung Cancer320
Complications
Tracheal perforation caused massive bleeding in one
patient with lung cancer. The patient underwent emer-
gency thoracotomy for tracheal resection and sleeve pneu-
monectomy and is still alive. Three of the 36 patients
(8.3%) died of sepsis within 2 weeks of the bronchoscopic
intervention. However, there was no intra-procedural death
in this study.
Additional Definitive Therapy
After stabilizing the airway with the bronchoscopic
treatment, additional definitive therapy was undertaken for 21
of the 36 patients (58.3%) (Table 3). Nine patients underwent
surgical resection. All nine of these patients had been rescued
by rigid bronchoscopic intervention to relieve respiratory
failure and subsequently underwent definitive surgery, for a
primary airway tumor in six patients, thyroid cancer in two,
FIGURE 1. Representative case of malignant central airway obstruction. A, A 70-year-old male patient showed mid-tra-
cheal obstruction on an initial three-dimensional computed tomographic scan. B, Bronchoscopy showed an endotracheal
mass almost completely obstructing the lumen. The biopsy identified adenoid cystic carcinoma. C, Because of mediasti-
nal invasion seen on the initial computed tomography, the patient underwent definitive radiotherapy after the emer-
gency bronchoscopic intervention. D, Six months after radiation, follow-up computed tomography showed complete res-
olution of the tumor.
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and lung cancer in one. Most patients were initially unable to
undergo because of severe respiratory distress. Twelve pa-
tients were treated with radiation therapy, 10 with radiation
alone, two with combination chemoradiation.
For the remaining 15 patients (41.7%), additional de-
finitive therapy could not be applied because of the exhaus-
tion of radiation or chemotherapy options (n  5), sepsis
(n  3), or the patient’s refusal (n  7).
Survival
The overall survival after airway intervention ranged
from 3 days to 69 months, with a median of 23.6 months.
Twenty-two of the 36 patients (61.1%) are known to have
died. Four deaths occurred during admission or within 30
days of the procedure as a result of sepsis (n  3) or disease
progression (n  1). There was no intra-procedural death in
this study.
Survival was plotted according to etiologic malignancy
(Fig. 2). Those with slowly growing cancers (adenoid cystic
carcinoma and thyroid cancer) had a longer survival, al-
though the difference was not statistically significant.
Survival was analyzed according to whether previous
or additional definitive therapy had been performed (Table 4).
Longer survival was observed for patients who underwent
additional definitive therapy after bronchoscopic intervention
(median, 38.2 months; range, 1.7 to 69.0 months) compared
with those who did not (median, 6.2 months; range, 0.1 to
33.7 months; p  0.001, log-rank test). In addition, longer
survival was observed for newly diagnosed patients who had
not undergone previous therapy (median, 37.2 months; range,
0.5 to 69.0 months) than for those who had undergone
previous therapy (median, 10.2 months; range, 0.1 to 33.7
months; p  0.004, log-rank test).
The probability of longer survival was greater for
patients who were newly diagnosed with no prior treatment
and who underwent additional definitive therapy after bron-
choscopic intervention (median, 44.9 months; range, 3.4 to
69.0 months) than for those who had both previous and
additional definitive therapy (median, 14.1 months; range, 1.7
to 30.3 months; p 0.005, log-rank test) or those who had no
additional definitive therapy (median, 6.2 months; range, 0.1
to 33.7 months; p  0.001, log-rank test) (Fig. 3).
DISCUSSION
Bronchoscopic evaluation is the key step in the treat-
ment of patients with malignant airway obstruction.1,2 Bron-
choscopy allows diagnostic confirmation and airway staging,
which are critical when considering surgery.6,8,9 For patients
with unresectable malignant airway obstruction, therapeutic
bronchoscopic intervention may provide significant pallia-
tion.3–5 In addition, for patients with respiratory failure
caused by malignant central airway obstruction, rigid bron-
TABLE 3. Additional definitive therapy after bronchoscopic
intervention
n (%)
Surgical resection 9 (25.0)
Palliative radiation therapy 10 (27.8)
Palliative combined chemotherapy and radiation therapy 2 (5.6)
None 15 (41.7)
FIGURE 2. Survival according to etiologic malignancy in
patients with central airway obstruction. ACC, adenoid cystic
carcinoma; Eso, esophageal cancer; Trac, primary tracheal
squamous cell carcinoma; MEC, mucoepidermoid carcinoma;
Blad, bladder cancer; HCC, hepatocellular carcinoma; RCC,
renal cell carcinoma).
TABLE 4. Survival according to previous and additional
therapy
Survival (mo)
Additional definitive therapy after intervention
Yes (n  21) 38.2 (1.7–69.0) p  0.001
No (n  15) 6.2 (0.1–33.7)
Previous therapy before intervention
Yes (n  20) 10.2 (0.1–33.7) p  0.004
No (n  16) 37.2 (0.5–69.0)
Values are median (range).
FIGURE 3. Survival according to whether previous or addi-
tional definitive therapy had been performed for patients
with malignant central airway obstruction.
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choscopic intervention may relieve life-threatening obstruc-
tion and provide a better opportunity for other definitive
therapeutic modalities, such as surgery, radiation, and che-
motherapy.3–5,9–11 This study showed that bronchoscopic in-
tervention improved the respiratory status of most patients
(34 of 36, 94.4%). Rigid bronchoscopy and treatment offer
the potential for palliation for severe dyspnea resulting from
malignant central airway obstruction.
We have performed rigid bronchoscopy for 8 years and,
in this study, report our data for a 5-year period. Most patients
with advanced cancer and life-threatening airway lesions
recover from general anesthesia successfully after broncho-
scopic intervention. The addition of definitive therapy (radi-
ation, chemotherapy, or surgery) after both bronchoscopic
intervention and newly diagnosed malignant airway disease
had favorable effects on the prognosis. As bronchoscopic
intervention is a palliative modality for malignant central
airway obstruction, definitive therapy is essential for long-
term survival. Survival was longer among patients who un-
derwent additional radiation or surgery after the emergency
bronchoscopic intervention than among those who did not. In
addition, survival was longer among patients who were newly
diagnosed than among those who had exhausted all options
for radiation, chemotherapy, and surgery before broncho-
scopic intervention.
Bronchoscopic intervention has a well-defined role for
palliation of malignant central airway obstruction,14 even in
patients on mechanical ventilation15 or who are terminally
ill.16 In this study, nine patients were able to undergo surgery
after emergency bronchoscopic intervention. These nine were
initially unable to undergo surgery because of respiratory
failure, but they recovered after successful bronchoscopic
intervention and were clinically able to undergo surgery.
Previous studies have also reported that initial bronchoscopic
relief of airway obstruction improves operability in highly
selected patients.8,9,13
There are clear limitations to our study. As the total
number of patients was 36, the subgroup analyses consisted
of small numbers of patients. More cases are needed to
confirm our results, but our findings are consistent with other
reports. In addition, the clinical outcome after bronchoscopic
intervention was scored according to the patient’s symptoms
and radiographic findings. Spirometric data for patients be-
fore and after treatment would have been ideal, but most
patients were too ill for baseline measurements. Although
there is no control group in our study with which to compare
treatment results, the life-threatening clinical status of our
patients does not lend itself to randomized trials.
In summary, rigid bronchoscopic intervention in criti-
cally ill patients with malignant central airway obstruction
may be temporarily life-saving and, in some patients, may
serve as a “bridge” to allow time for additional therapies for
longer survival.
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